{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:06:46Z","timestamp":1787170006725,"version":"build-2736575974"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":1272,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T00:00:00Z","timestamp":1561075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"publisher","award":["81572835"],"award-info":[{"award-number":["81572835"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"publisher","award":["81801429"],"award-info":[{"award-number":["81801429"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"publisher","award":["81870525"],"award-info":[{"award-number":["81870525"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shandong Key Research and Development Program","award":["2018GSF118118"],"award-info":[{"award-number":["2018GSF118118"]}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81572835"],"award-info":[{"award-number":["81572835"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81801429"],"award-info":[{"award-number":["81801429"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81870525"],"award-info":[{"award-number":["81870525"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shandong Key Research and Development Program","award":["2018GSF118118"],"award-info":[{"award-number":["2018GSF118118"]}]}],"content-domain":{"domain":["smoa.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Erectile dysfunction (ED) is highly prevalent in aging men. Tadalafil daily and on-demand are widely used for the treatment of ED.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>We performed a meta-analysis to evaluate the efficacy and safety of tadalafil daily compared with tadalafil on-demand in treating men with ED after at least 24 weeks of long-term treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Randomized controlled trials of tadalafil daily vs on-demand in treating men with ED were searched using MEDLINE, EMBASE, and the Cochrane Controlled Trials Register. Systematic review was carried out using the Preferred Reporting Items for Systematic Reviews and Meta-analyses. The data was calculated by RevMan version 5.3.0. The references of related articles were also searched.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes<\/jats:title>\n                    <jats:p>International Index of Erectile Function-Erectile Function domain, sexual encounter profile question 2 (SEP2), SEP question 3 (SEP3), any treatment-emergent adverse event (AE), discontinuation due to AEs, myalgia, back pain, headache, dyspepsia, and nasopharyngitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>4 articles, including 1,035 participants were studied. The analysis found that tadalafil daily had a greater improvement than tadalafil on-demand in terms of International Index of Erectile Function-Erectile Function (mean\u00a0difference (MD) 1.24; 95% CI 0.03\u22122.44; P\u00a0= .04), SEP2 (MD 10.08; 95% CI 9.15\u221211.01; P &amp;lt; .00001) and SEP3 (MD 8.19; 95% CI 2.09\u221214.29; P\u00a0= .009) in treating ED after at least 24 weeks treatment cycle. For safety, tadalafil on-demand had a higher incidence of any treatment-emergent AE (odds ratio 0.73; 95% CI 0.56\u22120.96; P\u00a0=\u00a0.02) compared with tadalafil daily, but for other aspects, including discontinuation due to AEs, myalgia, back pain, headache, dyspepsia, and nasopharyngitis, there were no significant difference between the 2 treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Implications<\/jats:title>\n                    <jats:p>Tadalafil daily may offer a better effect for ED than on-demand for long-term treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Strengths and Limitations<\/jats:title>\n                    <jats:p>From the perspective of evidence-based medicine, we evaluated the efficacy and safety of tadalafil daily compared with tadalafil on-demand in treating men with ED after a long-term treatment. The quality of these studies included is flawed, primarily in difference in tadalafil doses and severity of the ED.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Tadalafil daily provides a preferable therapeutic effect for ED with a lower incidence of treatment-emergent side effects relative to tadalafil on-demand after at least 24 weeks of long-term treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.esxm.2019.06.006","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T17:55:21Z","timestamp":1562954121000},"page":"282-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Meta-Analysis of the Long-Term Efficacy and Tolerance of Tadalafil Daily Compared With Tadalafil On-Demand in Treating Men With Erectile Dysfunction"],"prefix":"10.1093","volume":"7","author":[{"given":"Zhongbao","family":"Zhou","sequence":"first","affiliation":[{"name":"Binzhou Medical University , Yantai, Shandong \u00a0 China"},{"name":"Department of Urology , Yantai, Shandong \u00a0 China"},{"name":"The Affiliated Yantai Yuhuangding Hospital of Qingdao University , Yantai, Shandong \u00a0 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Urology , Yantai, Shandong \u00a0 China"},{"name":"The Affiliated Yantai Yuhuangding Hospital of Qingdao University , Yantai, Shandong \u00a0 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitao","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Urology , Yantai, Shandong \u00a0 China"},{"name":"The Affiliated Yantai Yuhuangding Hospital of Qingdao University , Yantai, Shandong \u00a0 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jipeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology , Yantai, Shandong \u00a0 China"},{"name":"The Affiliated Yantai Yuhuangding Hospital of Qingdao University , Yantai, Shandong \u00a0 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology , Yantai, Shandong \u00a0 China"},{"name":"The Affiliated Yantai Yuhuangding Hospital of Qingdao University , Yantai, Shandong \u00a0 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Urology , Yantai, Shandong \u00a0 China"},{"name":"The Affiliated Yantai Yuhuangding Hospital of Qingdao University , Yantai, Shandong \u00a0 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanshan","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Urology , Yantai, Shandong \u00a0 China"},{"name":"The Affiliated Yantai Yuhuangding Hospital of Qingdao University , Yantai, Shandong \u00a0 China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,7,12]]},"reference":[{"key":"2023012006101883600_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0140-6736(12)60520-0","article-title":"Erectile dysfunction","volume":"381","author":"Shamloul","year":"2013","journal-title":"Lancet"},{"key":"2023012006101883600_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0302-2838(03)00215-X","article-title":"Male erectile dysfunction and health-related quality of life","volume":"44","author":"S\u00e1nchez-Cruz","year":"2003","journal-title":"Eur Urol"},{"key":"2023012006101883600_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5489\/cuaj.2699","article-title":"2015 CUA Practice guidelines for erectile dysfunction","volume":"9","author":"Bella","year":"2015","journal-title":"Can Urol Assoc J"},{"key":"2023012006101883600_bib4","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1001\/jama.2016.12284","article-title":"Erectile Dysfunction","volume":"316","author":"Najari","year":"2016","journal-title":"JAMA"},{"key":"2023012006101883600_bib5","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.eururo.2010.02.020","article-title":"Guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation","volume":"57","author":"Hatzimouratidis","year":"2010","journal-title":"Eur Urol"},{"key":"2023012006101883600_bib6","doi-asserted-by":"crossref","first-page":"3848545","DOI":"10.1155\/2017\/3848545","article-title":"Chronic administration of tadalafil improves the symptoms of patients with amicrobic MAGI: An open study","volume":"2017","author":"La Vignera","year":"2017","journal-title":"Int J Endocrinol"},{"issue":"4 Pt 1","key":"2023012006101883600_bib7","first-page":"1332","article-title":"Efficacy and safety of tadalafil for the treatment of erectile dysfunction: Results of integrated analyses","volume":"168","author":"Brock","year":"2002","journal-title":"J\u00a0Urol"},{"key":"2023012006101883600_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0090-4295(03)00359-5","article-title":"Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: A randomized controlled trial","volume":"62","author":"Porst","year":"2003","journal-title":"Urology"},{"key":"2023012006101883600_bib9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.urology.2017.08.031","article-title":"The efficacy of tadalafil daily vs on demand in the treatment of erectile dysfunction: A systematic review and meta-analysis","volume":"112","author":"Bansal","year":"2018","journal-title":"Urology"},{"key":"2023012006101883600_bib10","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J\u00a0Clin Epidemiol"},{"key":"2023012006101883600_bib11","article-title":"Randomised controlled trials","author":"Jadad","year":"1998"},{"key":"2023012006101883600_bib12","author":"Higgins","year":"2011","journal-title":"Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [Internet]"},{"key":"2023012006101883600_bib13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"2023012006101883600_bib14","first-page":"415","article-title":"Comparison of efficacy, safety, and tolerability of on-demand tadalafil and daily dosed tadalafil for the treatment of erectile dysfunction","volume":"2","author":"McMahon","year":"2005","journal-title":"J\u00a0Sex Med"},{"key":"2023012006101883600_bib15","first-page":"1195","article-title":"Evaluation of the\u00a0efficacy of once-daily use of tadalafil vs. on-demand use. Is there a cumulative effect?","volume":"62","author":"Jamshidian","year":"2012","journal-title":"J\u00a0Pak Med Assoc"},{"key":"2023012006101883600_bib16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.eururo.2013.09.051","article-title":"Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: A randomised placebo-controlled study (REACTT)","volume":"65","author":"Montorsi","year":"2014","journal-title":"Eur Urol"},{"key":"2023012006101883600_bib17","first-page":"1592","article-title":"Adherence to initial PDE-5 inhibitor treatment: Randomized open-label study comparing tadalafil once a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction","volume":"10","author":"Buvat","year":"2013","journal-title":"J\u00a0Sex Med"},{"key":"2023012006101883600_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.ijir.3901496","article-title":"Tadalafil dosed once a day in men with erectile dysfunction: A randomized, double-blind, placebo-controlled study in the US","volume":"19","author":"Rajfer","year":"2007","journal-title":"Int J Impot Res"},{"key":"2023012006101883600_bib19","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.eururo.2004.04.026","article-title":"Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction","volume":"46","author":"Skoumal","year":"2004","journal-title":"Eur Urol"},{"key":"2023012006101883600_bib20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2125.2005.02553.x","article-title":"Tadalafil pharmacokinetics in healthy subjects","volume":"61","author":"Forgue","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"2023012006101883600_bib21","first-page":"1198","article-title":"Investigating women's preference for sildenafil or tadalafil use by their partners with erectile dysfunction: The partners' preference study","volume":"5","author":"Conaglen","year":"2008","journal-title":"J\u00a0Sex Med"},{"key":"2023012006101883600_bib22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000477496","article-title":"Efficacy and safety of tadalafil once-a-day versus tadalafil on-demand in patients with erectile dysfunction: A systematic review and meta-analyses","volume":"99","author":"Peng","year":"2017","journal-title":"Urol Int"},{"key":"2023012006101883600_bib23","first-page":"2039","article-title":"Safety, efficacy, and pharmacokinetic overview of low-dose daily administration of tadalafil","volume":"6","author":"Wrishko","year":"2009","journal-title":"J\u00a0Sex Med"},{"key":"2023012006101883600_bib24","first-page":"1418","article-title":"A\u00a0randomized open-label trial with a crossover comparison of sexual self-confidence and other treatment outcomes following tadalafil once a day vs tadalafil or sildenafil on-demand in men with erectile dysfunction","volume":"9","author":"Rubio-Aurioles","year":"2012","journal-title":"J\u00a0Sex Med"},{"key":"2023012006101883600_bib25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ijir.2014.15","article-title":"Psychosocial outcomes after initial treatment of erectile dysfunction with tadalafil once daily, tadalafil on demand or sildenafil citrate on demand: Results from a randomized, open-label study","volume":"26","author":"Hatzimouratidis","year":"2014","journal-title":"Int J Impot Res"},{"key":"2023012006101883600_bib26","first-page":"820","article-title":"Erectile dysfunction","volume":"94","author":"Rew","year":"2016","journal-title":"Am Fam Physician"},{"key":"2023012006101883600_bib27","first-page":"1146","article-title":"[Psychological factors involved in erectile dysfunction]","volume":"17","author":"Wang","year":"2011","journal-title":"Zhonghua Nan Ke Xue"},{"key":"2023012006101883600_bib28","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s11255-017-1644-5","article-title":"Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: A systematic review and meta-analysis","volume":"49","author":"Gong","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"2023012006101883600_bib29","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00345-018-2583-1","article-title":"Comparative efficacy and safety of phosphodiesterase type 5 inhibitors for erectile dysfunction in diabetic men: A Bayesian network meta-analysis of randomized controlled trials","volume":"37","author":"Liao","year":"2019","journal-title":"World J Urol"},{"key":"2023012006101883600_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/1008-682X.143244","article-title":"An open-label, multicenter, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in Chinese men naive to phosphodiesterase 5 inhibitor therapy","volume":"17","author":"Bai","year":"2015","journal-title":"Asian J Androl"},{"key":"2023012006101883600_bib31","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.eururo.2013.01.012","article-title":"Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: A systematic review and network meta-analysis","volume":"63","author":"Yuan","year":"2013","journal-title":"Eur Urol"}],"container-title":["Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050116119300650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050116119300650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/smoa\/article-pdf\/7\/3\/282\/48791770\/smoa_7_3_282.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/smoa\/article-pdf\/7\/3\/282\/48791770\/smoa_7_3_282.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T01:12:48Z","timestamp":1674177168000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/smoa\/article\/7\/3\/282\/6956490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,12]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.esxm.2019.06.006","relation":{},"ISSN":["2050-1161"],"issn-type":[{"value":"2050-1161","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,9]]},"published":{"date-parts":[[2019,7,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-Analysis of the Long-Term Efficacy and Tolerance of Tadalafil Daily Compared With Tadalafil On-Demand in Treating Men With Erectile Dysfunction","name":"articletitle","label":"Article Title"},{"value":"Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esxm.2019.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc. on behalf of the International Society for Sexual Medicine.","name":"copyright","label":"Copyright"}]}}